Monte Rosa Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.88

+0.17 (+1.08%)

As of Aug 8, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +142.1% upside

Low Target $28.40

Average Target $38.45

High Target $50.36

Current Price $15.88

Current
$15.88

Target
$38.45

$28.40 $38.45 avg $50.36

Scenario Analysis

Bear Case

$28.40

78.8%

Low target

Base Case

$38.45

+142.1%

Avg target

Bull Case

$50.36

+217.1%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$25.77

-38.4% from high

52-Week Low

$4.12

+285.4% from low

Target vs 52W High

$38.45

+49.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%